You're being conservative and I don't have a problem with that.

My view is that Dr. P's work is so definitive that the improvement from the drugged group will be so dramatic and that the decline of the placebo group will be significant enough that you won't need to go to the data to make the distinction. In other words, the data will still be analyzed, but unnecessary to draw the conclusion in favor of leronlimab. And again, if the results are as dramatic as I hope, then this government may be comfortable in touting it as a therapeutic treatment 'with promising test results' <-- get it?!